# Effect of Probiotic Lactobacilli (Lacidofil Cap®) for the Prevention of Antibiotic-Associated Diarrhea

> **NCT01058356** · — · COMPLETED · sponsor: **Pharmbio Korea Co., Ltd.** · enrollment: 214 (actual)

## Conditions studied

- Antibiotics Associated Colitis
- Pulmonary Infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01058356
- **Lead sponsor:** Pharmbio Korea Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2010-01
- **Final completion:** 2010-02
- **Target enrollment:** 214 (ACTUAL)
- **Last updated:** 2010-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01058356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01058356, "Effect of Probiotic Lactobacilli (Lacidofil Cap®) for the Prevention of Antibiotic-Associated Diarrhea". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01058356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*